ConductScience.org, home

Paper1900527

The iron chelator desferrioxamine (Desferal) retards 6-hydroxydopamine-induced degeneration of nigrostriatal dopamine neurons.

Ben-Shachar D and 3 others. J Neurochem, 1991. Cited by 281 papers, by iCite.

Cite this record

ConductScience Library. The iron chelator desferrioxamine (Desferal) retards 6-hydroxydopamine-induced degeneration of nigrostriatal dopamine neurons. Papers, record 1900527. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1900527

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The iron chelator desferrioxamine (Desferal) retards 6-hydroxydopamine-induced degeneration of nigrostriatal dopamine neurons.
PubMed
Journal
J Neurochem
PubMed
Year
1991
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
281
iCite
Relative citation ratio, by iCite
8.69
iCite
Revised in PubMed
2019-06-30
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ben-Shachar DD
2Eshel GG
3Finberg JPJ P
4Youdim MBM B

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DeferoxamineMajor topic
DopamineMajor topic
HydroxydopaminesMajor topic
Nerve DegenerationMajor topic
NeuronsMajor topic
Substantia NigraMajor topic
3,4-Dihydroxyphenylacetic Acid
Animals
Homovanillic Acid
Iron Chelating Agents
Male
Neurotoxins
Oxidopamine
Rats
Rats, Inbred Strains

Source PubMed

Download CSV of topics

Cited by70

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 281 citations.

PMIDTitleJournalYearIn PapersSource
41977458Acidosis, Iron Dyshomeostasis and Inflammatory Injury.Int J Mol Sci2026https://conductscience.org/library/papers/41977458PubMed
41258873Pathogenic mechanism underlying parkinsonism induced by neurotoxicants (MPTP and 6-hydroxydopamine) and α-synuclein: a unifying hypothesis.J Mol Cell Biol2025https://conductscience.org/library/papers/41258873PubMed
38731800The Role of Oxygen Homeostasis and the HIF-1 Factor in the Development of Neurodegeneration.Int J Mol Sci2024https://conductscience.org/library/papers/38731800PubMed
37892438Roles of Omega-3 Polyunsaturated Fatty Acids in Managing Cognitive Impairment in Chronic Obstructive Pulmonary Disease: A Review.Nutrients2023https://conductscience.org/library/papers/37892438PubMed
37062012Lewy bodies, iron, inflammation and neuromelanin: pathological aspects underlying Parkinson's disease.J Neural Transm (Vienna)2023https://conductscience.org/library/papers/37062012PubMed
36106206Depression in Parkinson's Disease: A Narrative Review.Cureus2022https://conductscience.org/library/papers/36106206PubMed
35922689LUHMES Dopaminergic Neurons Are Uniquely Susceptible to Ferroptosis.Neurotox Res2022https://conductscience.org/library/papers/35922689PubMed
35054862Mechanistic Insights Expatiating the Redox-Active-Metal-Mediated Neuronal Degeneration in Parkinson's Disease.Int J Mol Sci2022https://conductscience.org/library/papers/35054862PubMed
34721835Neuroprotective Effects of Estradiol plus Lithium Chloride via Anti-Apoptosis and Neurogenesis Pathway in In Vitro and In Vivo Parkinson's Disease Models.Parkinsons Dis2021https://conductscience.org/library/papers/34721835PubMed
34299316Redox-Active Metal Ions and Amyloid-Degrading Enzymes in Alzheimer's Disease.Int J Mol Sci2021https://conductscience.org/library/papers/34299316PubMed
33799121Parkinson's disease: Alterations in iron and redox biology as a key to unlock therapeutic strategies.Redox Biol2021https://conductscience.org/library/papers/33799121PubMed
33419006Inflaming the Brain with Iron.Antioxidants (Basel)2021https://conductscience.org/library/papers/33419006PubMed
33028106The Association Between Parkinson's Disease and Attention-Deficit Hyperactivity Disorder.Cell Transplant2020https://conductscience.org/library/papers/33028106PubMed
32650609The Role of Oxidative Stress in Parkinson's Disease.Antioxidants (Basel)2020https://conductscience.org/library/papers/32650609PubMed
32424108Clioquinol improves motor and non-motor deficits in MPTP-induced monkey model of Parkinson's disease through AKT/mTOR pathway.Aging (Albany NY)2020https://conductscience.org/library/papers/32424108PubMed
31960628Intranasal deferoxamine can improve memory in healthy C57 mice, suggesting a partially non-disease-specific pathway of functional neurologic improvement.Brain Behav2020https://conductscience.org/library/papers/31960628PubMed
318944186-Hydroxydopamine: a far from simple neurotoxin.J Neural Transm (Vienna)2020https://conductscience.org/library/papers/31894418PubMed
31440200Mobility Deficits Assessed With Mobile Technology: What Can We Learn From Brain Iron-Altered Animal Models?Front Neurol2019https://conductscience.org/library/papers/31440200PubMed
30341696Monoamine oxidase inhibitors, and iron chelators in depressive illness and neurodegenerative diseases.J Neural Transm (Vienna)2018https://conductscience.org/library/papers/30341696PubMed
28984871How do we fit ferroptosis in the family of regulated cell death?Cell Death Differ2017https://conductscience.org/library/papers/28984871PubMed

See all 70 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1900527

GET https://conductscience.org/api/papers/v1/1900527/cited_by?page=2